Related Experiment Video
Updated: Oct 8, 2025

Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments
Published on: February 7, 2025
Proteoglycan Endocan: A multifaceted therapeutic target in Cancer
Ke-Fan Pan1, Yi-Chieh Yang2, Wei-Jiunn Lee3
1Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Abstract:
Endocan is known to be a circulating dermatan sulfate proteoglycan that regulates endothelial cell function. Dysregulation of endocan expression is observed not only in the tumor vasculature but also in cancer cells. Accumulating evidence has revealed that disordered endocan facilitates cancer progression via enhancing cancer cell proliferation, cell mobility, and cancer stemness properties. Recently, various interacting proteins and diverse subcellular localizations of endocan were identified in cancer cells. Herein, we summarize the application of endocan in cancer diagnoses and prognoses using serum and tumor specimens. We further discuss that the aberrant molecular characteristics of endocan may be due to the mislocalization of endocan in cancer cells. Defining the specific cellular roles of endocan will provide a promising diagnostic factor and therapeutic target for cancer patients.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Proteoglycans
Mitogens and the Cell Cycle
Matrix Proteoglycans and Glycoproteins
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Tumor Immunotherapy

